nonprofit logo

Cbset Inc

Learn about this cause: Is it Legit? Do I like the mission? What is the CEO's salary?

EIN: 204325286 ✦ Lexington, MA ✦ Designated as a 501(c)(3)

Overview

What is Cbset Inc?

Cbset Inc, based in Lexington, Massachusetts, is a research-focused nonprofit organization. Their primary mission encompasses the advancement of science and education in the realm of novel diagnostic, therapeutic, surgical medical devices, and imaging technologies. These developments aim to facilitate early disease diagnosis and the creation of innovative treatments for complex conditions. The organization specializes in minimally invasive techniques in various fields, including cardiology, endoscopy, surgery, drug and device delivery, drug and device safety, and diagnostic imaging. Cbset Inc's commitment extends beyond research, as they also work to improve regulatory insight and research methods.


Official website here: www.cbset.org

Is Cbset Inc legitimate?

Cbset Inc is a legitimate nonprofit organization registered as a 501(c)(3) entity. Cbset Inc submitted a form 990, which is a tax form used by tax-exempt organizations in the U.S., indicating its operational transparency and adherence to regulatory requirements. Donations to this organization are tax deductible.

Here are some key statistics you may want to consider:

Executive Compensation: $0
Professional Fundraising Fees: $0
Other Salaries and Wages: $7,389,101

For more financial information, click here


Official website here: www.cbset.org

What is the mission statement of Cbset Inc?

Cbset Inc is committed to driving research, education, and advancement in the field of early stage technologies. Their mission is to assist their sponsors in creating distinctive tools and innovative methods, focusing on early diagnosis and effective treatments for intricate diseases. Cbset Inc excels in the development and implementation of novel minimally invasive techniques, primarily in the areas of cardiology, endoscopy, surgery, drug and device delivery, diagnostic imaging, drug safety, and device safety.


Official website here: www.cbset.org

Who is the CEO of Cbset Inc?

Peter Markham is the Director of Cbset Inc.


Official website here: www.cbset.org

What is the revenue of Cbset Inc?

Cbset Inc's revenue in 2022 was $25,153,452.


Official website here: www.cbset.org

Who are the executives of Cbset Inc and what are their salaries?

Here are 8 key members and their salaries:

    Peter Markham (Pres/Exec Dir) [Trustee/Director]
  • Compensation: $648,600
  • Related: $0
  • Other: $25,480

    • John Keating (Pathologist)
  • Compensation: $286,112
  • Related: $0
  • Other: $15,744

    • Misty Williams-Fritze (Director Of Vet Services)
  • Compensation: $264,907
  • Related: $0
  • Other: $26,910

    • Raffaele Melidone (Senior Pathologist)
  • Compensation: $247,894
  • Related: $0
  • Other: $27,829

    • Michael Naimark (Director Of Business Development)
  • Compensation: $250,389
  • Related: $0
  • Other: $25,152

    • Campbell Rogers (Board Director)
  • Compensation: $10,000
  • Related: $0
  • Other: $0

    • Adam Groothuis (Treas/Clerk/Consultant) [Trustee/Director]
  • Compensation: $10,000
  • Related: $0
  • Other: $0

    • Elazer Edelman (Director)
  • Compensation: $0
  • Related: $0
  • Other: $0


  • Official website here: www.cbset.org

    Where can I find the form 990 for Cbset Inc?

    The Cbset Inc’s most recent form 990 was submitted in 2022 and can be accessed here


    Official website here: www.cbset.org

    Learn more at the official website: www.cbset.org

    Mission Statement of Cbset Inc

    Cbset Inc, a dedicated organization, is committed to driving research, education, and advancement in the realm of early-stage technologies. With a mission to help their sponsors, Cbset Inc focuses on developing distinctive tools and innovative methods for promoting early diagnosis and discovering groundbreaking treatments for intricate diseases. The organization boasts expertise in various fields, including cardiology, endoscopy, surgery, drug and device delivery, drug and device safety, and diagnostic imaging.

    Cbset Inc's unwavering dedication to innovation is evident in the novel minimally invasive techniques it specializes in. These techniques have the potential to revolutionize industries such as cardiology, endoscopy, and surgery, providing new solutions to complex medical challenges. Through their work, Cbset Inc not only strives to push the boundaries of science but also aims to improve healthcare outcomes and enhance the quality of life for patients.

    In the fields of cardiology, for instance, Cbset Inc's research and development efforts may lead to the creation of advanced diagnostic tools or minimally invasive surgical procedures. In endoscopy, the organization's innovative techniques could pave the way for less invasive and more efficient diagnostic procedures. And in surgery, Cbset Inc's work may result in the development of less invasive surgical methods, reducing the risk of complications and recovery time for patients.

    Overall, Cbset Inc's mission is to support and accelerate the development of unique solutions for complex diseases, with a focus on early diagnosis and novel treatments. Their specialized knowledge and expertise in various fields make them an invaluable partner for organizations and institutions seeking to make a difference in the realm of healthcare.

    Impact

    This information is meant to be a general summary of Cbset Inc. Please take the time to review official sources before making any decisions based upon the content provided here.




    Thursday, August 15, 2024

    Cbset Inc's impact can be seen through its dedication to research, education, and advancement of early stage technologies in the medical field. By focusing on novel diagnostic, therapeutic, surgical medical device, and imaging technologies used in the diagnosis and treatment of disease, Cbset aims to advance science and education, improve regulatory insight, advance research methods, and ultimately enhance diagnosis, patient care, and treatment of diseases.

    With a mission to help sponsors develop unique tools and novel methods for early diagnosis and innovative treatments for complex diseases, Cbset specializes in the development and application of novel minimally invasive techniques in various medical fields such as cardiology, endoscopy, surgery, drug and device delivery, drug and device safety, and diagnostic imaging. Through their work, Cbset is making significant contributions to improving healthcare outcomes and pushing the boundaries of medical technology.





    Financials

    This financial information is from Propublica.

    Revenue
    Expenses
    Efficiency

    Other financial information:

    This information is from the most recently submitted tax form from this organization, which was in 2022.

  • Investment Income: $69,403
  • Program Service Revenue: $25,084,049
  • Gross Receipts: $25,153,452

    • Assets and Liabilities:
  • Total Assets: $23,766,998
  • Total Liabilities: $12,122,718
  • Net Assets: $11,644,280
  • Programs

    Programs are reported by nonprofits in their tax forms and are normally their tax-exempt activities.

    STUDY INCOME - GENERAL

    Revenue

    $23,172,793

    STUDY INCOME - HEARING

    Revenue

    $1,616,913

    SUPPLIES INCOME

    Revenue

    $162,260

    REVENUE - GRAFTON

    Revenue

    $82,083

    CONSULTING INCOME

    Revenue

    $50,000

    Organization Details

    Founding Year

    2006

    Principal Officer

    Peter Markham

    Main Address

    500 SHIRE WAY, LEXINGTON, MA, 02421

    NTEE Category

    Code: E05 - Health

    If you are a representative of Cbset Inc and wish to learn more about how Give Freely can help you raise funds, please click here: https://givefreely.com/nonprofits/. Our services are offered at no cost to your organization.